Single product sales reps

[compound26]

Oct 26, 2017 10:55:14 GMT -5 sportsrancho said:

Oct 25, 2017 5:58:24 GMT -5 falconquest said:

This has been chief among my concerns beyond financing. The financing had to be in place to keep the company running but beyond that we need to move product. This really bothers me that we haven't seen more success. Yes, there are arguments about insurance coverage etc., etc. but we should still see better sales by now in my opinion. I would love to hear from Reps. what they are hearing in the field from doctors.

DM me:-)

As long as we see stead growth of TRx, even if it is slow, I am not concerned.

Whether we break even in one year, two years or three years. That will be fine with me.

Many people here are expecting exponential growth of scripts now or at some point. I do not expect that to happen. Of course, if it happens, I will be overwhelmed. However, exponential growth is not what I expect and IMHO Mannkind can succeed with current trajectory (small stead growth month to month (or over 4-week rolling periods)).  

To sum up, I am not disappointed at the current scripts growth trajectory. 

And I do not share the view that if our growth does not pick up quickly Mannkind will start losing their current reps. If our growth remains at the current rate, we will be doing just fine. 

kimi just gave the projected TRx using the current growth trajectory and got the following numbers (see the original post here: mnkd.proboards.com/post/127638):

            26 weeks: 651

            52 weeks: 1014 --> projected annual sales $45 Mill

            104 weeks: 2459 --> p.a.s. §108 Mill

If that will be the actual numbers we will get, I am totally fine with that. 

And if the above math shows that we are not on track to meet the lower end of management's projection for 2H2017 revenue, I am fine with that.

And if our management needs to lower that guidance at upcoming conference call, I am fine with that too.

To me, the only requirement for the management is that we are on track to break even eventually. I just want them to finish the race. I do not need them to break any record.

[peppy]

Oct 26, 2017 11:31:02 GMT -5 compound26 said:

Oct 26, 2017 10:55:14 GMT -5 sportsrancho said:

DM me:-)

As long as we see stead growth of TRx, even if it is slow, I am not concerned.

Whether we break even in one year, two years or three years. That will be fine with me.

Many people here are expecting exponential growth of scripts now or at some point. I do not expect that to happen. Of course, if it happens, I will be overwhelmed. However, exponential growth is not what I expect and IMHO Mannkind can succeed with current trajectory (small stead growth month to month (or over 4-week rolling periods)).  

To sum up, I am not disappointed at the current scripts growth trajectory. 

And I do not share the view that if our growth does not pick up quickly Mannkind will start losing their current reps. If our growth remains at the current rate, we will be doing just fine. 

kimi just gave the projected TRx using the current growth trajectory and got the following numbers (see the original post here: mnkd.proboards.com/post/127638):

            26 weeks: 651

            52 weeks: 1014 --> projected annual sales $45 Mill

            104 weeks: 2459 --> p.a.s. §108 Mill

If that will be the actual numbers we will get, I am totally fine with that. 

And if the above math shows that we are not on track to meet the lower end of management's projection for 2H2017 revenue, I am fine with that.

And if our management needs to lower that guidance at upcoming conference call, I am fine with that too.

To me, the only requirement for the management is that we are on track to break even eventually. I just want them to finish the race. I do not need them to break any record.

And if the above math shows that we are not on track to meet the lower end of management's projection for 2H2017 revenue, I am fine with that.